Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Sold by Guggenheim Capital LLC

Guggenheim Capital LLC reduced its position in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 32.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,070 shares of the semiconductor company's stock after selling 2,875 shares during the period. Guggenheim Capital LLC's holdings in Silicon Laboratories were worth $754,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Jones Financial Companies Lllp raised its position in shares of Silicon Laboratories by 44.5% during the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock valued at $28,000 after buying an additional 69 shares during the period. Headlands Technologies LLC purchased a new stake in Silicon Laboratories in the fourth quarter valued at $70,000. Venturi Wealth Management LLC lifted its stake in shares of Silicon Laboratories by 207.0% in the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company's stock valued at $98,000 after purchasing an additional 530 shares during the last quarter. Asset Management One Co. Ltd. purchased a new position in shares of Silicon Laboratories during the 4th quarter worth $117,000. Finally, KBC Group NV increased its position in shares of Silicon Laboratories by 42.1% during the 4th quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock worth $159,000 after purchasing an additional 379 shares during the last quarter.

Silicon Laboratories Trading Down 0.4 %

NASDAQ:SLAB traded down $0.37 during trading hours on Monday, hitting $102.39. The company's stock had a trading volume of 119,402 shares, compared to its average volume of 326,033. The stock has a fifty day moving average of $116.65 and a 200-day moving average of $121.08. The stock has a market capitalization of $3.32 billion, a P/E ratio of -17.23 and a beta of 1.33. Silicon Laboratories Inc. has a 52-week low of $82.82 and a 52-week high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business had revenue of $166.25 million during the quarter, compared to the consensus estimate of $166.09 million. During the same quarter in the previous year, the firm earned ($1.19) EPS. The company's revenue was up 91.4% compared to the same quarter last year. On average, sell-side analysts forecast that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.

Analyst Upgrades and Downgrades

SLAB has been the subject of several research reports. KeyCorp lifted their target price on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an "overweight" rating in a report on Wednesday, January 22nd. Barclays decreased their target price on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 22nd. Needham & Company LLC reaffirmed a "buy" rating and issued a $150.00 target price on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Benchmark reissued a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Finally, StockNews.com lowered shares of Silicon Laboratories from a "hold" rating to a "sell" rating in a research note on Thursday, March 27th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $129.00.

Insider Buying and Selling

In other news, Director William G. Bock sold 1,000 shares of Silicon Laboratories stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total value of $149,430.00. Following the transaction, the director now directly owns 31,115 shares of the company's stock, valued at $4,649,514.45. The trade was a 3.11 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Navdeep S. Sooch sold 2,360 shares of the firm's stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the transaction, the director now directly owns 400,567 shares in the company, valued at $59,684,483. The trade was a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.